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INTRODUCTION:  Solitary  cavernous  lymphangioma  is very  rare  disease  characterized  by abnormally  pro-
liferating  lymphatic  vessels.  We  report  a 49-year-old  woman  with  a cavernous  pulmonary  lymphangioma
showing  rapid  growth  after  remaining  indolent  for  10 years.
PRESENTATION  OF CASE:  Chest  computed  tomography  revealed  a solitary,  poorly  demarcated  mass  in  the
left lower  lobe;  however,  the tumour  grew  in  size  over  the  next  6  months.  A  left  lower  lobectomy  was
performed  following  suspected  lung  cancer.  Histopathological  and  immunohistochemical  analysis  of theulmonary lymphangioma
horcoscopic surgery
mmunohistochemical ﬁndings
resected  specimens  revealed  a pulmonary  cavernous  lymphangioma.
DISCUSSION:  It  is  difﬁcult  to  make  an  accurate  diagnosis  of solitary  cavernous  lymphangioma  by imaging
ﬁndings,  therefore  a surgical  resection  is  recommended  as  the diagnostic  and  therapeutic  modality.
CONCLUSION:  A pulmonary  lymphangioma  should  be included  in the  differential  diagnosis  of a  rapidly
growing  tumour.
©  2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
he CCaccess  article  under  t
. Introduction
Lymphangiom is a rare and benign disease presenting as a con-
enital lymphatic malformation that arises because of a defect in
ud development [1]. While thoracic lymphangiomas are usually
bserved in the mediastinum, pulmonary lesions are not very com-
on. Pulmonary lymphangiomas are well known to frequently
xhibit a cystic form on computed tomography (CT). Therefore, if
 pulmonary tumour has a non-cystic appearance on the CT, it is
mportant to differentiate it from lung cancer. Herein, we  report a
ase of a rapidly growing solitary cavernous pulmonary lymphan-
ioma mimicking a malignant tumour.
. Presentation of case
A 49-year-old woman who underwent left mastectomy for
reast cancer 10 years ago had a suspicious lesion in her lung that
as detected on preoperative chest CT. She did not receive the
eep X-day therapy for the treatment of breast cancer, but received
djuvant chemotherapy consisting of four courses of vinorelbine
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(25 mg/m2) and docetaxel (60 mg/m2), followed by endocrine ther-
apy (20 mg  daily tamoxifen administration for ﬁve years and 3.6 mg
monthly goserelin injection for three years). Although CT examina-
tions performed every year revealed no changes in the abnormal
mass during ten year-postoperative follow-up sessions, the lesion
recently grew larger over a 6-month period. She was admitted to
our outpatient clinic complaining of a dry cough and low-grade
fever that manifested 1 month before the growth was  detected
on CT. She was a never smoker and had no family history of
malignancy. Except for anaemia due to hypermenorrhoea, physi-
cal examinations and other laboratory tests (including for tumour
markers) did not reveal any abnormalities.
On her ﬁrst visit of our hospital, the chest CT scan demon-
strated a non-cystic poorly demarcated mass, 3.9 × 2.2 cm in
size in the lower lobe of the left lung (Figs. 1A and B).
Transbronchial lung biopsy did not result in a deﬁnite diagno-
sis. 18F-ﬂuorodeoxyglucose-positron emission tomography (PET)
showed slight accumulation; the maximum standardized uptake
value was 2.26. A subsequent CT scan after 6 months showed obvi-
ous tumour growth to 4.5 × 3.0 cm (Figs. 1C and D). After surgical
resection of this tumour was indicated suspecting malignancy, the
patient underwent a video-assisted thoracoscopic left lower lobec-
tomy followed by mediastinal lymph node dissection. The mass
was located on the root of the left inferior pulmonary vein, and
intraoperative pathologic evaluation did not rule out malignancy.
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Fig. 1. Axial (A) and coronal sections (B) of high-resolution computed tomography (CT) scans of the lung demonstrating a poorly demarcated mass, measuring 3.9 × 2.2 cm
in  diameter, in the lower lobe of the left lung. Axial (C) and coronal sections (D) of the subsequent CT scan 6 months later showing tumour growth, measuring 4.5 × 3.0 cm.
Fig. 2. Histologic analysis shows multiple cystic spaces, containing lymph ﬂuid, surrounding the bronchus (A). An immunohistochemical examination revealed that the
monolayer epithelial cells lining the wall of the cyst were positive for cluster of differentiation antigen 31 and D2-40 (B and C, respectively). B and C are magniﬁcations of
the  area indicated by the square in A.
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icroscopic observation revealed spread cavernous spaces con-
aining lymph ﬂuid surrounding the bronchus (Fig. 2A). A single
ayer of endothelium lined the cyst wall. Immunohistochemical
taining of these cells showed positivity for cluster of differenti-
tion antigen 31 (CD31) and D2-40, which is a speciﬁc lymphatic
essel marker (Figs. 2B and C). The tumour was thus diagnosed as
 pulmonary lymphangioma.
The postoperative course was uneventful; the patient was  dis-
harged on postoperative day 4 and is currently well with no signs
f recurrence 2 years after surgery.
. Discussion
Lymphangioma is a rare, benign vascular malformation of the
ymphatic system composed of cystically dilated lymphatic vessels.
hile lymphangioma is known to affect any part of the body, the
ost common sites are the neck (75%) and axilla (20%). 1Although
t is not uncommon for thoracic lymphangiomas to be found in the
ediastinum, where they account for 0.7% to 4.5% of all mediasti-
al tumours, pulmonary lymphangiomas are extremely rare [2].
he clinical manifestation of pulmonary lymphangioma is depen-
ent on the age of the patient and the extent of the tumour. In
dults, such tumours may  remain asymptomatic and are found inci-
entally on chest radiography or CT, as occurred in the present
ase. Conversely, symptoms related to compressions of adjacent
natomic structures, such as cough, dyspnoea, vocal cord paralysis,
enous compression, stridor, or dysphagia often occur in children.
Lymphangioma subtypes are histologically classiﬁed as cys-
ic, cavernous, or capillary, and tumour development generally
epends on the tissue density of the surrounding structure. Cystic
ymphangiomas most commonly appear around fat tissue where
here is little resistance to their growth; these lymphangiomas
nclude cervical, axial, and mediastinal lesions. On the other hand,
avernous or capillary lymphangiomas often appear around mus-
ular tissues, such as the lip, cheek, or tongue, where the resistance
f the surrounding tissue is greater [3]. The majority of lung lym-
hangiomas are characterized by a cystic structure; solitary lung
ymphangioma with a non-cystic appearance (as in the present
ase) appears to be rare. The rapid growth of the tumour may  be
wing to the softer parenchyma of the lung.
It is extremely rare for pulmonary lymphangiomas to exhibit
apid growth after remaining indolent for 10 years. Lymphan-
iomas appear to originate from the aberrant development of the
ymphatic system, whereas secondary forms develop in adults
wing to lymphatic channel obstruction caused by radiation,
urgery, or infection [3]. Since histologic obstruction of the lymph
essel was not detected in this patient, it is reasonable to assume
hat an infection may  have induced the tumour to grow, especially
s slight accumulation was observed on PET.
Solitary lymphangioma of the lung is difﬁcult to diagnose
sing imaging; according to a series of published reports, surgical
esection is recommended for diagnosis and determination of the
herapeutic intervention method [4,5]. The lymphatic properties
f such tumours are difﬁcult to clarify histopathologically, and the
etection of immunohistochemical markers such as CD31, D2-40,
nd lymphatic vessel endothelial receptor 1 is useful for diagno-
is of lymphangioma. D2-40 in particular is a more speciﬁc marker
han the other proteins [6,7].
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4. Conclusion
We  experienced a rapidly growing pulmonary cavernous lym-
phangioma. Our case suggests that pulmonary lymphangioma
should be included in the differential diagnosis of a rapidly growing
pulmonary tumour, and surgical resection is recommended as the
diagnostic and therapeutic modality.
Consent
Written informed consent was  obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
Funding
None.
Conﬂicts of interest
All authors have no competing interests.
Ethical approval
None.
Author contributions
Shinji Shinohara and Ryoichi Nakanishi conceived and designed
the report. Manabu Yasuda contributed to the clinical management
of the patients. Ryoichi Nakanishi, Manabu Yasuda and Fumihiro
Tanaka reviewed and revised the manuscript. All the authors read
and approved the ﬁnal manuscript.
Guarantor
Shinji Shinohara.
References
1] E.P. Feutz, H.Y. Yune, I. Mandelbaum, R.E. Brashear, Intrathoracic cystic
hygroma. A report of three cases, Radiology 108 (1973) 61–66.
2] K. Shaffer, M.L. Rosado-de-Christenson, E.F. Patz Jr., S. Young, C.F. Farver,
Thoracic lymphangioma in adults: CT and MR  imaging features, Am.  J.
Roentgeno.l 162 (1994) 283–289.
3] J.L. Faul, G.J. Berry, T.V. Colby, S.J. Ruoss, M.B. Walter, G.D. Rosen, T.A. Rafﬁn,
Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and
lymphatic dysplasia syndrome, Am.  J. Respir. Crit. Care Med. 161 (2000)
1037–1046.
4] S. Yamagishi, K. Koizumi, T. Hirata, K. Hirai, J. Kurita, K. Shimizu, Experience of
thoracoscopic extirpation of intrapulmonary lymphangioma, Jpn. J. Thorac.
Cardiovasc. Surg. 53 (6) (2005) 313–316.
5] S. Limmer, M. Krokowski, P. Kujath, Pulmonary lymphangioma, Ann. Thorac.
Surg. 85 (2008) 336–339.
6] J. Nakajima, A. Goto, S. Takamoto, T. Murakawa, T. Fukami, M.  Kusakabe,
Invasive lymphangioma of the lung manifesting as a large pulmonary mass
with hemoptysis: report of a case, Surg. Today 37 (5) (2007) 418–422.
7] J. Bhawan, C. Silva, W.M.  Taungjaruwinai, Inconsistent immunohistochemical
expression of lymphatic and blood endothelial cell markers in cutaneous
lymphangiomas, J. Cutan. Pathol. 40 (2013) 801–806.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
